Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Veranova Fentanyl Hydrochloride

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Fentanyl Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bankrupt Insys offers to turn out its almost empty pockets for plaintiffs
    Bankrupt Insys offers to turn out its almost empty pockets for plaintiffs

    23 Nov 2019

    // K. Blankenship FIERCE PHARMA

    https://www.fiercepharma.com/pharma/insys-offers-to-settle-opioid-claims-last-days-bankruptcy-liquidation

    K. Blankenship FIERCE PHARMA
    23 Nov 2019
    Share Share
    Bankrupt Insys cleared to sell opioid spray Subsys in $20M deal
    Bankrupt Insys cleared to sell opioid spray Subsys in $20M deal

    21 Sep 2019

    // K. Blankenship FIERCE PHARMA

    https://www.fiercepharma.com/pharma/bankrupt-insys-cleared-to-sell-addictive-fentanyl-spray-subsys-deal-could-net-20m

    K. Blankenship FIERCE PHARMA
    21 Sep 2019
    Share Share
    Facing $4B in claims, Insys doubts ability to pay out via Chapter 11
    Facing $4B in claims, Insys doubts ability to pay out via Chapter 11

    21 Sep 2019

    // Andrew Dunn BIOPHARMADIVE

    https://www.biopharmadive.com/news/facing-4b-in-claims-insys-doubts-ability-to-pay-out-via-chapter-11/563389/

    Andrew Dunn BIOPHARMADIVE
    21 Sep 2019
    Share Share
    Study links opioid epidemic to painkiller marketing
    Study links opioid epidemic to painkiller marketing

    18 Jan 2019

    // Gene Emery REUTERS

    https://uk.reuters.com/article/us-health-opioids-drug-companies/study-links-opioid-epidemic-to-painkiller-marketing-idUKKCN1PC1Z6

    Gene Emery REUTERS
    18 Jan 2019
    Share Share
    DEA Issues Safety Alert About Potent Opioid
    DEA Issues Safety Alert About Potent Opioid

    18 Mar 2015

    // PHARMACEUTICAL MANUFACTURING

    http://www.pharmamanufacturing.com/industrynews/2015/dea-issues-safety-alert-about-potent-opiod/

    PHARMACEUTICAL MANUFACTURING
    18 Mar 2015
    Share Share